1. Home
  2. YHC vs VRAX Comparison

YHC vs VRAX Comparison

Compare YHC & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LQR House Inc.

YHC

LQR House Inc.

N/A

Current Price

$1.80

Market Cap

2.2M

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$3.16

Market Cap

2.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
YHC
VRAX
Founded
2021
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2M
2.3M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
YHC
VRAX
Price
$1.80
$3.16
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
164.2K
52.5K
Earning Date
04-15-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,120,622.00
N/A
Revenue This Year
$1,267.57
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
86.42
N/A
52 Week Low
$0.02
$0.10
52 Week High
$2.72
$13.19

Technical Indicators

Market Signals
Indicator
YHC
VRAX
Relative Strength Index (RSI) 55.72 55.52
Support Level $0.71 $0.22
Resistance Level $2.20 $4.75
Average True Range (ATR) 0.20 0.28
MACD -0.04 -0.04
Stochastic Oscillator 44.26 33.12

Price Performance

Historical Comparison
YHC
VRAX

About YHC LQR House Inc.

LQR House Inc intends to become the full-service digital marketing and brand development face of the alcoholic beverage space. It also intends to integrate the supply, sales, and marketing facets of the alcoholic beverage space into one easy-to-use platform and become the one-stop shop for everything related to alcohol. The company's primary business includes the development of premium limited-batch spirit brands, establishing an exclusive wine club, and marketing internal and external brands through an exclusive agreement with a United States-based e-commerce portal. It believes that the marketing and brand management services it provides to its wholly owned and third-party clients will increase brand recognition, and drive sales thereof through its e-commerce platform partner.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: